Should You Be Bullish on Arcellx (ACLX)? [Yahoo! Finance]
Arcellx, Inc. (ACLX)
Company Research
Source: Yahoo! Finance
A copy of the same can be downloaded here . The fund advanced 8.92% (Institutional Shares) in the quarter compared to an 8.52% gain for the Russell 3000 Health Care Index (benchmark) and a 10.56% increase for the S&P 500 Index. The fund rose 13.61% on an annualized basis since its inception on April 30, 2018, compared to an 11.45% gain for the benchmark and a 14.24% gain for the index. In addition, please check the fund's top five holdings to know its best picks in 2024. Baron Health Care Fund featured stocks like Arcellx, Inc. (NASDAQ: ACLX ) in its Q1 2024 investor letter. Headquartered in Redwood City, California, Arcellx, Inc. (NASDAQ:ACLX) engages in the development of various immunotherapies for patients with cancer and other incurable diseases. On April 22, 2024, Arcellx, Inc. (NASDAQ:ACLX) stock closed at $52.00 per share. One-month return of Arcellx, Inc. (NASDAQ:ACLX) was -21.39%, and its shares gained 34.20% of their value over the last 52 weeks. Arcellx, Inc. (NASDAQ:ACL
Show less
Read more
Impact Snapshot
Event Time:
ACLX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACLX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACLX alerts
High impacting Arcellx, Inc. news events
Weekly update
A roundup of the hottest topics
ACLX
News
- Arcellx, Inc. (NASDAQ: ACLX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $81.00 price target on the stock.MarketBeat
- Arcellx to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceBusiness Wire
- Arcellx, Inc. (NASDAQ: ACLX) had its "outperform" rating re-affirmed by analysts at Scotiabank. They now have a $82.00 price target on the stock.MarketBeat
- Arcellx to Participate at the H.C. Wainwright 2nd Annual Cell Therapy Virtual ConferenceBusiness Wire
- Arcellx, Inc. (NASDAQ: ACLX) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $82.00 price target on the stock.MarketBeat
ACLX
Earnings
- 11/13/23 - Miss
ACLX
Sec Filings
- 5/3/24 - Form 4
- 4/18/24 - Form 4
- 4/11/24 - Form ARS
- ACLX's page on the SEC website